Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Intra-arterial Chemotherapy in the Treatment Strategy of Metastatic Spinal Disease

NCT01637766 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT01637766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01637766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Intra-arterial Chemotherapy in the Treatment Strategy of Metastatic Spinal Disease
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal diseases, spinal metastases, spinal tumors